Pet medicine report lookup / Melarsomine / Dogs

What has been reported to the FDA for Melarsomine in dogs?

Short answer: The FDA has received 22,745 adverse event reports for dogs that name Melarsomine. The FDA lists 2 approved animal drug applications containing Melarsomine for dogs, the earliest approved in 2017. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Melarsominein dogs
22,745reports to the FDA

The FDA has received 22,745 adverse event reports for dogs that name Melarsomine.

  1. 22,745 reports name Melarsomine in dogs, which is 2.3% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
  2. 41% are marked serious and 5.8% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
  3. 33% are complaints that the product did not work (38% across all dog reports).
  4. The clinical signs reported most are ineffective, heartworm adults, lack of efficacy (endoparasite) - heartworm and vomiting.
  5. The FDA lists 2 approved animal drug applications containing Melarsomine for dogs, the earliest approved in 2017.
  6. None of this is a rate. The FDA data does not record how many dogs were given Melarsomine, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll dog reports
Marked seriousthe FDA record flags the report as serious9,27841%29%
Death or euthanasiathe outcome recorded in the report, with no finding of cause1,3115.8%5.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event7,40533%38%
Seizurea seizure or convulsion is among the clinical signs4462.0%4.4%
Not used per labelthe report says the product was not used the way its label directs4,50520%21%

Where on the body do the reported signs sit?

23%15%9.7%5.2%

Not on the body: Did not work 28% Whole body 14%

  1. Did not work28%ineffective, heartworm adults, lack of efficacy (endoparasite) - heartworm, ineffective, heartworm larvae, lack of efficacy
  2. Stomach and gut23%vomiting, anorexia, diarrhoea, hypersalivation and 2 more
  3. Where it was applied15%injection site swelling, injection site pain, injection site lump
  4. Whole body14%pain, lethargy, fever, death
  5. Heart and breathing9.7%cough, panting, polypnoea, cardiac disorder
  6. Behaviour5.2%depression, restlessness
  7. Blood and organ tests3.0%elevated alanine aminotransferase (alt)
  8. Brain and nerves1.8%ataxia

Each figure is a share of sign mentions among the 25 signs reported most for Melarsomine in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. INEFFECTIVE, HEARTWORM ADULTS4,219 19%
  2. Lack of efficacy (endoparasite) - heartworm2,840 12%
  3. Vomiting2,736 12%
  4. Injection site swelling2,292 10%
  5. Injection site pain1,470 6.5%
  6. Pain1,286 5.7%
  7. Anorexia1,220 5.4%
  8. Diarrhoea1,192 5.2%

Reports received per year

1,14202012: 951 reports2013: 871 reports2014: 930 reports2015: 979 reports2016: 1,121 reports2017: 1,142 reports2018: 1,106 reports2019: 1,022 reports2020: 1,097 reports2021: 1,022 reports2022: 935 reports2023: 684 reports2024: 790 reports2025: 705 reports2026: 339 reports20122014201620182020202220242026first approved for dogs
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 1,142 reports (2017). The earliest FDA approval for dogs was in 2017.

Is it approved for dogs?

DogsFDA-approved product listed
Catsno approved product found
Other animalsnone found
FDA-approved for dogs

The FDA lists 2 approved animal drug applications containing Melarsomine for dogs, the earliest approved in 2017.

ProductFormApproved forFirst approvedFDA application
DirobanAnzac Animal Health, LLCPowder RXDog2017200-609
Immiticide Sterile PowderBoehringer lngelheim Animal Health USA, Inc.Liquid (Solution) RXDog141-042

From the FDA record for Diroban: <p>Not for use in breeding animals and lactating or pregnant bitches. The drug is contraindicated in dogs with class 4 (very severe) heartworm disease (Caval Syndrome). Administer only by deep intramuscular injection in the lumbar muscles (L3 - L5). [continues in the FDA record]

What can you do next?

Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save